Natto: Daniel Rosenbaum, MBA, Named COO of NattoPharma USA, Inc.
Daniel H. Rosenbaum has been appointed as Chief Operating Officer of NattoPharma USA, Inc. Rosenbaum will work from the NattoPharma US office in New Jersey, and report to CEO Hogne Vik, located in Norway.“The employment of Daniel H. Rosenbaum reflects a swift in our company and points to the opportunity for a significant growth of the science-backed vitamin K2 market for MenaQ7” says Frode M. Bohan, Chairman of NattoPharma ASA, Høvik, Norway. “Rosenbaum has a strong nettwork within the omega-3- and dietary supplement industry. This, in combination with the increasing business potential